作者: Sadamu Kurono , Yuka Kaneko , Nariaki Matsuura , Shuji Matsuura
DOI:
关键词:
摘要: The present invention relates to: a breast cancer marker which is selected from the group consisting of carboxypeptidase N subunit 2, extracellular matrix protein 1, serum amyloid P component, nebulin, complement component C8 α chain, apolipoprotein L1, flavin reductase, catalase, carbonic anhydrase C-I, nuclear pore glycoprotein 210, superoxide dismutase [Cu-Zn], bisphosphoglycerate mutase, 1 and peroxiredoxin 2; method for determining cancer, comprises detecting in sample on basis results detection; kit use method.